UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeted therapy for hepatocellular carcinoma

Signal transduction and targeted therapy, 2020-08, Vol.5 (1), p.146, Article 146

2020

Volltextzugriff (PDF)

A Positive Feedback Loop Between Cancer Stem‐Like Cells and Tumor‐Associated Neutrophils Controls Hepatocellular Carcinoma Progression

Hepatology (Baltimore, Md.), 2019-10, Vol.70 (4), p.1214-1230

2019

Volltextzugriff (PDF)

Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma

Clinical cancer research, 2014-12, Vol.20 (23), p.6212-6222

2014

Volltextzugriff (PDF)

STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4

Molecular cancer, 2017-08, Vol.16 (1), p.136-15, Article 136

2017

Volltextzugriff (PDF)

Circulating stem cell–like epithelial cell adhesion molecule–positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection

Hepatology (Baltimore, Md.), 2013-04, Vol.57 (4), p.1458-1468

2013

Volltextzugriff (PDF)

CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis

Journal of hematology and oncology, 2019-04, Vol.12 (1), p.37-17, Article 37

2019

Volltextzugriff (PDF)

A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA

Cancer letters, 2019-05, Vol.450, p.98-109

2019

Volltextzugriff (PDF)

Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study

The lancet oncology, 2012-08, Vol.13 (8), p.817-826

2012

Volltextzugriff (PDF)

Necessary and Sufficient Consensus Conditions of Descriptor Multi-agent Systems

IEEE transactions on circuits and systems. I, Regular papers, 2012-11, Vol.59 (11), p.2669-2677

2012

Volltextzugriff (PDF)

Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma

Clinical cancer research, 2018-02, Vol.24 (3), p.547-559

2018

Volltextzugriff (PDF)

Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma

Cell death & disease, 2020-07, Vol.11 (7), p.573, Article 573

2020

Volltextzugriff (PDF)

Hsa_circ_0003945 promotes progression of hepatocellular carcinoma by mediating miR‐34c‐5p/LGR4/β‐catenin axis activity

Journal of cellular and molecular medicine, 2022-04, Vol.26 (8), p.2218-2229

2022

Volltextzugriff (PDF)

Establishment of a hepatocellular carcinoma patient‐derived xenograft platform and its application in biomarker identification

International journal of cancer, 2020-03, Vol.146 (6), p.1606-1617

2020

Volltextzugriff (PDF)

Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantation

Liver international, 2021-03, Vol.41 (3), p.562-573

2021

Volltextzugriff (PDF)

ASO Author Reflections: Annexin A3 as a Potential Biomarker for Hepatocellular Carcinoma

Annals of surgical oncology, 2019-12, Vol.26 (Suppl 3), p.529-530

2019

Volltextzugriff (PDF)

Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma

Clinical cancer research, 2018-05, Vol.24 (9), p.2203-2213

2018

Volltextzugriff (PDF)

Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma

Journal of hepatology, 2017-08, Vol.67 (2), p.293-301

2017

Volltextzugriff (PDF)

Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic target

BMC cancer, 2019-08, Vol.19 (1), p.760-12, Article 760

2019

Volltextzugriff (PDF)

MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53

Cancer letters, 2019-09, Vol.459, p.156-167

2019

Volltextzugriff (PDF)

The treatment strategy and outcome for spontaneously ruptured hepatocellular carcinoma: a single-center experience in 239 patients

Journal of cancer research and clinical oncology, 2022-11, Vol.148 (11), p.3203-3214

2022

Volltextzugriff (PDF)

Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance

Journal of cancer research and clinical oncology, 2011-08, Vol.137 (8), p.1151-1173

2011

Volltextzugriff (PDF)

Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform

Clinical cancer research, 2014-09, Vol.20 (18), p.4794-4805

2014

Volltextzugriff (PDF)

Circulating CD14+HLA‐DR−/low myeloid‐derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery

Hepatology research, 2017-09, Vol.47 (10), p.1061-1071

2017

Volltextzugriff (PDF)

Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study

Signal transduction and targeted therapy, 2023-03, Vol.8 (1), p.106-10, Article 106

2023

Volltextzugriff (PDF)

High expression of Dickkopf‐related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery

Cancer, 2013-03, Vol.119 (5), p.993-1003

2013

Volltextzugriff (PDF)

1 – 25 von 843

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(691)
Mit Volltextzugriff
(730)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(718)
Chinesisch
(127)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(534)
Life Sciences & Biomedicine
(350)
Humans
(198)
Male
(141)
Physical Sciences
(132)
Female
(126)
Technology
(102)
Middle Aged
(94)
Animals
(85)
Oncology
(83)
Hepatocellular Carcinoma
(79)
Adult
(73)
Chemistry
(66)
Liver Cancer
(60)
Aged
(54)
Physics
(54)
Prognosis
(54)
Materials Science
(53)
Engineering
(51)
Materials Science, Multidisciplinary
(47)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Targeted therapy for hepatocellular carcinoma

A Positive Feedback Loop Between Cancer Stem‐Like Cells and Tumor‐Associated Neutrophils Controls Hepatocellular Carcinoma Progression

Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma

STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4

Circulating stem cell–like epithelial cell adhesion molecule–positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection

CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis

A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA

Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study

Necessary and Sufficient Consensus Conditions of Descriptor Multi-agent Systems

Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma

Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma

Hsa_circ_0003945 promotes progression of hepatocellular carcinoma by mediating miR‐34c‐5p/LGR4/β‐catenin axis activity

Establishment of a hepatocellular carcinoma patient‐derived xenograft platform and its application in biomarker identification

Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantation

ASO Author Reflections: Annexin A3 as a Potential Biomarker for Hepatocellular Carcinoma

Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma

Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma

Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic target

MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53

The treatment strategy and outcome for spontaneously ruptured hepatocellular carcinoma: a single-center experience in 239 patients

Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance

Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform

Circulating CD14+HLA‐DR−/low myeloid‐derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery

Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study

High expression of Dickkopf‐related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery

Suchergebnisse filtern